Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Unique Bella Sidelined Due to Shin Issue
- Classic Empire to Arkansas Derby After Impressive Work
- Steve Haskin's Derby Dozen - March 28, 2017
- Arrogate Last to First in Dubai World Cup
- Tepin Refuses to Work March 27 at Palm Meadows
- McCraken, Gunnevera Top Kentucky Derby Future Wager
- Tapit Colt Tops Barretts Hips to Watch
- Arrogate and How We Define Greatness
- Tumblebrutus Gets 25th Black-Type Winner
- Fasig-Tipton Adds New Sale Aimed at Turf Prospects